PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $14,000 | +7.7% | 428 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $13,000 | -35.0% | 428 | 0.0% | 0.01% | -36.4% |
| Q4 2017 | $20,000 | +25.0% | 428 | 0.0% | 0.01% | +10.0% |
| Q3 2017 | $16,000 | -20.0% | 428 | 0.0% | 0.01% | -23.1% |
| Q2 2017 | $20,000 | 0.0% | 428 | 0.0% | 0.01% | +8.3% |
| Q1 2017 | $20,000 | +42.9% | 428 | 0.0% | 0.01% | +33.3% |
| Q4 2016 | $14,000 | -6.7% | 428 | 0.0% | 0.01% | -10.0% |
| Q3 2016 | $15,000 | +7.1% | 428 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $14,000 | -39.1% | 428 | 0.0% | 0.01% | -44.4% |
| Q1 2016 | $23,000 | -32.4% | 428 | -2.9% | 0.02% | -30.8% |
| Q4 2015 | $34,000 | +466.7% | 441 | +194.0% | 0.03% | +420.0% |
| Q3 2015 | $6,000 | -45.5% | 150 | 0.0% | 0.01% | -37.5% |
| Q2 2015 | $11,000 | -15.4% | 150 | 0.0% | 0.01% | -11.1% |
| Q1 2015 | $13,000 | 0.0% | 150 | 0.0% | 0.01% | -10.0% |
| Q4 2014 | $13,000 | -13.3% | 150 | 0.0% | 0.01% | -23.1% |
| Q3 2014 | $15,000 | +7.1% | 150 | 0.0% | 0.01% | 0.0% |
| Q2 2014 | $14,000 | +40.0% | 150 | 0.0% | 0.01% | +18.2% |
| Q1 2014 | $10,000 | +11.1% | 150 | 0.0% | 0.01% | +120.0% |
| Q4 2013 | $9,000 | -25.0% | 150 | -40.0% | 0.01% | -28.6% |
| Q3 2013 | $12,000 | +71.4% | 250 | 0.0% | 0.01% | +40.0% |
| Q2 2013 | $7,000 | – | 250 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |